Open AccessSerum miR‑210‑3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis
Author(s) -
Małgorzata Guz,
Witold Jeleniewicz,
Marek Cybulski,
Joanna Kozicka,
Jacek Kurzepa,
Agnieszka Mądro
Publication year - 2020
Publication title -
biomedical reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.607
H-Index - 25
eISSN - 2049-9442
pISSN - 2049-9434
DOI - 10.3892/br.2020.1386
Subject(s) - oncogene , pancreatic ductal adenocarcinoma , pancreatitis , molecular medicine , medicine , cell cycle , adenocarcinoma , pancreatic cancer , cancer research , microrna , apoptosis , gastroenterology , pathology , cancer , oncology , biology , gene , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom